Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer

Author(s)

de Souza, Marilesia Ferreira ; Kuasne, Hellen ; Barros-Filho, Mateus de Camargo ; Ciliao, Heloisa Lizotti ; Marchi, Fabio Albuquerque ; Fuganti, Paulo Emilio ; Paschoal, Alexandre Rossi ; Rogatto, Silvia Regina ; de Syllos Colus, Ilce Mara

• Document type: Journal article
• Source: PLoS One; v. 12, n. 9 SEP 14 2017.
• Web of Science Citations: 23

Abstract

Circulating nucleic acids are found in free form in body fluids and may serve as minimally invasive tools for cancer diagnosis and prognosis. Only a few studies have investigated the potential application of circulating mRNAs and microRNAs (miRNAs) in prostate cancer (PCa). The Cancer Genome Atlas (TCGA) database was used for an in silico analysis to identify circulating mRNA and miRNA as potential markers of PCa. A total of 2,267 genes and 49 miRNAs were differentially expressed between normal and tumor samples. The prediction analyses of target genes and integrative analysis of mRNA and miRNA expression revealed eleven genes and eight miRNAs which were validated by RT-qPCR in plasma samples from 102 untreated PCa patients and 50 cancer-free individuals. Two genes, OR51E2 and SIM2, and two miRNAs, miR-200c and miR-200b, showed significant association with PCa. Expression levels of these transcripts distinguished PCa patients from controls (67% sensitivity and 75% specificity). PCa patients and controls with prostate-specific antigen (PSA) <= 4.0 ng/mL were discriminated based on OR51E2 and SIM2 expression levels. The miR-200c expression showed association with Gleason score and miR-200b, with bone metastasis, bilateral tumor, and PSA > 10.0 ng/mL. The combination of circulating mRNA and miRNA was useful for the diagnosis and prognosis of PCa. (AU)

• FAPESP's process: 08/57887-9 - National Institute of Oncogenomics
• Grantee: Luiz Paulo Kowalski
• Support Opportunities: Research Projects - Thematic Grants